SCHEMBL15413504

SCHEMBL15413504

O=C1c2cccc(O)c2C(=O)c2c(O)cc(-c3ccc(O)cc3)cc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
MAPT P10636 3/20 0.62
TSHR P16473 3/20 0.62
TDP1 Q9NUW8 3/20 0.62
MAOA P21397 3/20 0.62
MAPK1 P28482 2/20 0.62
LMNA P02545 2/20 0.62
HPGD P15428 2/20 0.62
ALOX15 P16050 2/20 0.62
MAOB P27338 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
HSD17B10 Q99714 2/20 0.62
HTT P42858 1/20 0.62
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
KDM4E B2RXH2 2/20 0.60
CYP3A4 P08684 2/20 0.60
RECQL P46063 2/20 0.60
ELANE P08246 2/20 0.60
USP2 O75604 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16656217 0.84 TTR (0.60) ALDH1A1MAPTTSHRTDP1MAOA
SCHEMBL15413406 0.84 PSMB11 (0.62) ALDH1A1MAPTTSHRTDP1MAOA
SCHEMBL29928697 0.82 ALDH1A1 (0.74) ALDH1A1MAPTTSHRTDP1MAOA
SCHEMBL8199540 0.82 ALDH1A1 (0.74) ALDH1A1MAPTTSHRTDP1MAOA
SCHEMBL22909075 0.81 ALDH1A1 (0.62) ALDH1A1MAPTTSHRTDP1MAOA
SCHEMBL16912725 0.81 MEN1 (0.51) ALDH1A1MAPTTSHRTDP1MAOA
Danthron SCHEMBL29356886 0.79 MAPT (1.00) ALDH1A1MAPTTSHRTDP1MAOA
Danthron SCHEMBL30544826 0.79 MAPT (1.00) ALDH1A1MAPTTSHRTDP1MAOA
Danthron SCHEMBL83688 0.79 MAPT (1.00) ALDH1A1MAPTTSHRTDP1MAOA
SCHEMBL15413385 0.79 MEN1 (0.49) ALDH1A1MAPTTSHRTDP1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-01-28 US disclosed
CN-110526827-A Anthraquinone analogs and its preparation and application UNIV GEORGIA STATE RES FOUND 2019-12-03 CN disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
EP-2872474-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF Georgia State University Research Foundation, Inc. (US) 2015-05-20 EP disclosed
CN-104507902-A Anthraquinone analogs and methods of making and using the same UNIV GEORGIA STATE RES FOUND 2015-04-08 CN disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL ALDH1A1 1562/4885MAPT 4878/4885TSHR 4555/4885
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof PCNA, KRAS, RECQL ALDH1A1 1562/4885MAPT 4878/4885TSHR 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.